SCHEMBL30906544

CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O

nearest known ligand 0.63

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	10/20	0.62

▸	CCKBR	P32239	2/20	0.61

▸	CRHR1	P34998	1/20	0.60

▸	CRHR2	Q13324	1/20	0.60

▸	GCGR	P47871	3/20	0.59

▸	CALCR	P30988	4/20	0.59

▸	F2	P00734	1/20	0.59

▸	NPY1R	P25929	1/20	0.59

▸	NPY2R	P49146	1/20	0.59

▸	NPY4R	P50391	1/20	0.59

▸	NPY5R	Q15761	1/20	0.59

▸	C5AR1	P21730	1/20	0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30906445	0.98	GLP1R (0.63)	GLP1RCCKBRGCGRCALCRF2
SCHEMBL30906405	0.98	GLP1R (0.62)	GLP1RCCKBRGCGRCALCRF2
SCHEMBL30906343	0.95	GLP1R (0.65)	GLP1RCCKBRCRHR1CRHR2GCGR
SCHEMBL30906528	0.94	GLP1R (0.63)	GLP1RCCKBRGCGRC5AR1
SCHEMBL30906418	0.92	NPY1R (0.57)	GLP1RNPY1RNPY2RNPY4RNPY5R
SCHEMBL30906407	0.89	GLP1R (0.58)	GLP1R
SCHEMBL30906357	0.88	NPY1R (0.57)	GLP1RNPY1RNPY2RNPY4RNPY5R
SCHEMBL30824285	0.88	F2 (0.66)	GLP1RCCKBRGCGRCALCRF2
SCHEMBL30658267	0.88	CALCR (0.69)	GLP1RCCKBRCRHR1CRHR2GCGR
SCHEMBL29450228	0.87	F2 (0.60)	GLP1RCCKBRCALCRF2NPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed